Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Item No. 35302

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWBradykinin fragment (1-5) is a metabolite of the endogenous vasodilator bradykinin (Item No. 37408).1 It is formed from bradykinin by angiotensin-converting enzyme (ACE). Bradykinin fragment (1-5) (100 nM) increases the production of nitric oxide (NO) in neonatal rat cardiomyocytes.2 It inhibits α-thrombin-induced platelet aggregation of washed isolated platelets (IC50 = 0.5 mM).3 Bradykinin fragment (1-5) prevents decreases in mean arterial blood pressure and heart rate and increases survival in a rat model of LPS-induced septicemia.4
WARNING This product is not for human or veterinary use.
1. Metabolism of bradykinin in aorta of hypertensive rats. Acta Biochim. Pol. 58(2), 199-202 (2011).
2. Peptide fragments of bradykinin show unexpected biological activity not mediated by B1 or B2 receptors. Br. J. Pharmacol. 179(12), 3061-3077 (2022).
3. Bradykinin and its metabolite, Arg-
4. A metabolic fragment of bradykinin, Arg-